Skip to main content

Table 5 GAD and PHQ measures at baseline and follow-up

From: A pilot study of a nurse-led integrated care review (the INCLUDE review) for people with inflammatory rheumatological conditions in primary care: feasibility study findings

 

All

Control

Intervention

 

Baseline

6 months

Baseline

6 months

Baseline

6 months

GAD-7

 Mild anxiety (score 0–5)

208 (62)

173 (52)

110 (65)

93 (55)

98 (60)

80 (49)

 Moderate anxiety (6–10)

75 (23)

56 (17)

39 (23)

33 (19)

36 (22)

23 (14)

 Moderately severe anxiety (11–15)

36 (11)

21 (6)

16 (9)

10 (6)

20 (12)

11 (7)

 Severe anxiety(16–21)

10 (3)

10 (3)

3 (2)

3 (2)

7 (5)

7 (4)

 Missing

4 (1)

73 (22)

2 (1)

31 (18)

2 (1)

42 (26)

PHQ-8

 Insignificant depression (score 0–4)

176 (53)

154 (46)

92 (54)

85 (50)

84 (52)

69 (42)

 Mild depression (5–9)

86 (26)

57 (17)

44 (26)

31 (18)

42 (26)

26 (16)

 Moderate depression (10–14)

39 (12)

25 (8)

17 (10)

8 (5)

22 (13)

17 (10)

 Moderately severe depression (15–19)

20 (6)

15 (5)

10 (6)

10 (6)

10 (6)

5 (3)

 Severe depression (20–24)

10 (3)

8 (2)

6 (3)

4 (2)

4 (2)

4 (2)

 Missing

2 (1)

74 (22)

1 (1)

31 (19)

1 (1)

42 (26)